Revolution Medicines (RVMD) closed at $192.28 on November 6, 2026, up 8.2% from the previous close, on volume of 4,283,972 shares (30-day average 2,025,345).
Data as of November 6, 2026.
Stifel Nicolaus Keeps Their Buy Rating on Revolution Medicines (RVMD)
TipRanks (Thu, 5-Nov 4:47 PM ET)
TipRanks (Thu, 5-Nov 2:00 PM ET)
Revolution Medicines (RVMD) Gets a Buy from Leerink Partners
TipRanks (Thu, 5-Nov 9:29 AM ET)
TipRanks (Thu, 5-Nov 8:41 AM ET)
Revolution Medicines (RVMD) Gets a Buy from Oppenheimer
TipRanks (Thu, 5-Nov 8:27 AM ET)
Revolution Medicines (RVMD) Gets a Buy from Wedbush
TipRanks (Thu, 5-Nov 7:56 AM ET)
Revolution Medicines (RVMD) Gets a Buy from RBC Capital
TipRanks (Thu, 5-Nov 7:38 AM ET)
At a glance: stocks gapping up premarket
Seeking Alpha News (Thu, 5-Nov 7:25 AM ET)
Guggenheim Sticks to Its Buy Rating for Revolution Medicines (RVMD)
TipRanks (Thu, 5-Nov 7:16 AM ET)
TipRanks (Thu, 5-Nov 6:40 AM ET)
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Revolution Medicines trades on the NASDAQ stock market under the symbol RVMD.
As of November 6, 2026, RVMD stock price climbed to $192.28 with 4,283,972 million shares trading.
RVMD has a beta of 2.39, meaning it tends to be more sensitive to market movements. RVMD has a correlation of 0.17 to the broad based SPY ETF.
RVMD has a market cap of $41.21 billion. This is considered a Large Cap stock.
Last quarter Revolution Medicines reported $198 million in Revenue and -$1.90 earnings per share. This beat revenue expectation by $170 million and exceeded earnings estimates by $.47.
In the last 3 years, RVMD traded as high as $224.31 and as low as $18.79.
The top ETF exchange traded funds that RVMD belongs to (by Net Assets): VTI, VB, VBK, VXF, IBB.
RVMD has outperformed the market in the last year with a price return of +224.0% while the SPY ETF gained +9.6%. RVMD has also outperformed the stock market ETF in the last 3 month and 2 week periods returning -2.5% and +2.4%, respectively, while the SPY returned -4.2% and -3.8%, respectively.
RVMD support price is $171.76 and resistance is $183.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RVMD shares will trade within this expected range on the day.
